Colossal Biosciences, the Dallas company working to bring back the woolly mammoth and Tasmanian tiger, is one step closer to its ambitious goals after generating the first high-quality reference genome of an African elephant.
The de-extinction company is working in partnership with the Vertebrate Genomes Project to ensure the survival of elephant species. The work illustrates a step forward in animal conservation and the future advances of Colossal’s efforts. Last year, the partnership announced a near complete sequence of the Asian elephant genome.
The woolly mammoth shares 99.6% of DNA with the Asian elephant, according to Colossal.
